Dualyx raises €40 million to progress Treg therapies

Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting

Related Keywords

Munich , Bayern , Germany , Dublin , Ireland , Paris , France General , France , New York , United States , Netherlands , Leuven , Gelderland , Milan , Lombardia , Italy , Belgium , Singapore , Bernard Coulie , Lucy Featherstone , Aneta Sottil , Juliette Audet , Luc Van Rompaey , Andera Croissance , Wouter Verhoeven , Bandera Co , Novartis , Ghent University , Consilium Strategic Communications , Wurzburg University , Andera Life Sciences , Fountain Healthcare Partners , Independent Chairman , Andera Partners , V Bio Ventures , Pliant Therapeutics , Van Rompaey , Healthcare Partners , Newamsterdam Pharma , United Nations Principles , Andera Midcap , Andera Expansion , Andera Co Invest , Andera Acto , Andera Infra , Gefallene Big Techs , Dualyx , Raises , Billion , Progress , Greg , Therapies , Autoimmune , Diseases , Clinic ,